home / stock / dare / dare quote
Last: | $0.4902 |
---|---|
Change Percent: | -0.18% |
Open: | $0.55 |
Close: | $0.4902 |
High: | $0.5599 |
Low: | $0.49 |
Volume: | 542,515 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4902 | $0.55 | $0.4902 | $0.5599 | $0.49 | 542,515 | 03-28-2024 |
$0.549 | $0.499 | $0.549 | $0.55 | $0.49 | 307,920 | 03-27-2024 |
$0.4983 | $0.53 | $0.4983 | $0.53 | $0.493 | 157,333 | 03-26-2024 |
$0.515 | $0.4845 | $0.515 | $0.53 | $0.48 | 439,365 | 03-25-2024 |
$0.4784 | $0.485 | $0.4784 | $0.485 | $0.45001 | 118,499 | 03-22-2024 |
$0.475 | $0.5 | $0.475 | $0.5 | $0.463 | 217,656 | 03-21-2024 |
$0.4629 | $0.503 | $0.4629 | $0.5275 | $0.43 | 1,002,554 | 03-20-2024 |
$0.51 | $0.52 | $0.51 | $0.53 | $0.503 | 119,843 | 03-19-2024 |
$0.51 | $0.499 | $0.51 | $0.53 | $0.47 | 330,391 | 03-18-2024 |
$0.4684 | $0.459 | $0.4684 | $0.48 | $0.45 | 149,261 | 03-15-2024 |
$0.4552 | $0.4633 | $0.4552 | $0.48 | $0.45 | 167,303 | 03-14-2024 |
$0.4603 | $0.46 | $0.4603 | $0.48 | $0.451 | 136,975 | 03-13-2024 |
$0.4601 | $0.5051 | $0.4601 | $0.5195 | $0.45 | 192,615 | 03-12-2024 |
$0.5003 | $0.509 | $0.5003 | $0.5196 | $0.495 | 106,570 | 03-11-2024 |
$0.4951 | $0.5 | $0.4951 | $0.52 | $0.49 | 223,934 | 03-08-2024 |
$0.493 | $0.52 | $0.493 | $0.5209 | $0.4811 | 342,890 | 03-07-2024 |
$0.5223 | $0.5527 | $0.5223 | $0.5527 | $0.5012 | 387,136 | 03-06-2024 |
$0.563 | $0.57 | $0.563 | $0.58 | $0.531 | 372,908 | 03-05-2024 |
$0.5501 | $0.5499 | $0.5501 | $0.57 | $0.48 | 462,162 | 03-04-2024 |
$0.5499 | $0.58 | $0.5499 | $0.5899 | $0.54 | 576,268 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Dare Bioscience Inc. Company Name:
DARE Stock Symbol:
NASDAQ Market:
2023 Highlights and Anticipated 2024 Milestones XACIATO™ (clindamycin phosphate) vaginal gel 2% is available by prescription in the United States to treat bacterial vaginosis under license agreement with commercial collaborator Organon Ovaprene® hormone-free mont...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 28, 2024, to revie...